CN Stock MarketDetailed Quotes

688606 Hangzhou Alltest Biotech

Watchlist

72.11
-3.33-4.41%

Market Closed Mar 21 15:00 CST

5.72BMarket Cap20.67P/E (TTM)

Hangzhou Alltest Biotech Stock Forum

Moomoo AI

Mar 1, 2024 07:35

Hangzhou Alltest Biotech's low ROE and net income growth are worrisome. Despite profit retention, the low ROE indicates that investors may not be reaping benefits. The company's growth lags behind industry average, raising concerns. Future earnings growth and its effect on stock price need assessment.